Patents by Inventor René Rijnbrand

René Rijnbrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric GB virus B (GBV-B)
    Patent number: 7473772
    Abstract: The present invention relates generally to the fields of biochemistry, molecular biology, and virology. More particularly, it relates to the identification of GB virus B (GBV-B)/HCV chimeras. The invention involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5? NTR derived from a HCV 5? NTR. This construct, and chimeric versions of it, may be employed to study GBV-B and related hepatitis family members, such as hepatitis C virus. The invention thus includes methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions.
    Type: Grant
    Filed: July 2, 2003
    Date of Patent: January 6, 2009
    Assignees: The Board of Regents of The University of Texas System, Institut Pasteur
    Inventors: Annette Martin, David V. Sangar, Stanley M. Lemon, Rene Rijnbrand
  • Chimeric GB virus B (GBV-B)
    Patent number: 7141405
    Abstract: The present invention relates generally to the fields of biochemistry, molecular biology, and virology. More particularly, it relates to the identification of GB virus B (GBV-B)/HCV chimeras. The invention involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5? NTR derived from a HCV 5? NTR. This construct, and chimeric versions of it, may be employed to study GBV-B and related hepatitis family members, such as hepatitis C virus. The invention thus includes methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions.
    Type: Grant
    Filed: July 3, 2002
    Date of Patent: November 28, 2006
    Assignees: Board of Regents, The University of Texas System, Institut Pasteu
    Inventors: Annette Martin, David V. Sangar, Stanley M. Lemon, René Rijnbrand
  • Chimeric gb virus b (gbv-b)
    Publication number: 20060160067
    Abstract: The present invention relates generally to the fields of biochemistry, molecular biology, and virology. More particularly, it relates to the identification of GB virus B (GBV-B)/HCV chimeras. The invention involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5? NTR derived from a HCV 5? NTR. This construct, and chimeric versions of it, may be employed to study GBV-B and related hepatitis family members, such as hepatitis C virus. The invention thus includes methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions.
    Type: Application
    Filed: July 2, 2003
    Publication date: July 20, 2006
    Inventors: Annette Martin, David Sangar, Stanley Lemon, Rene Rijnbrand
  • Chimeric GB virus B (GBV-B)
    Publication number: 20040039187
    Abstract: The present invention relates generally to the fields of biochemistry, molecular biology, and virology. More particularly, it relates to the identification of GB virus B (GBV-B)/HCV chimeras. The invention involves nucleic acid constructs and compositions encoding GBV-B/HCV chimera, including at least part of a 5′ NTR derived from a HCV 5′ NTR. This construct, and chimeric versions of it, may be employed to study GBV-B and related hepatitis family members, such as hepatitis C virus. The invention thus includes methods of preparing GBV-B/HCV chimeric sequences, constructs, and viruses, as well as methods of employing these compositions.
    Type: Application
    Filed: July 3, 2002
    Publication date: February 26, 2004
    Applicant: Board of Regents, The University of Texas System and Institut Pasteur
    Inventors: Annette Martin, David V. Sangar, Stanley M. Lemon, Rene Rijnbrand